Evolus Stock

Evolus Forward P/E

The Forward P/E Ratio of Evolus (EOLS) as of Aug 10, 2026 is -5.40. In the previous year, Forward P/E Ratio was -5.53 — a change of -2.36% (higher).

Forward P/E

-5.40

YoY

-2.36%

Last updated:

Forward P/E Ratio of Evolus is 2026 -5.40 . Forward P/E Ratio of Evolus was 2025 -5.53 . It decreases by -2.36% higher compared to the previous year.
Access this data via the Eulerpool API

Evolus Stock analysis

What does Evolus do? Evolus Inc is an innovative biotechnology company based in Irvine, California, specializing in the development and distribution of aesthetic treatments. The company was founded in 2012 and has quickly become a market leader in the industry. Evolus is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Evolus stock

Forward P/E Ratio of Evolus is -5.40 in 2026.

Forward P/E Ratio of Evolus changed from -5.53 to -5.40, representing a -2.36% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio Evolus since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's Evolus with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Evolus

All Key Metrics — Evolus